4Accepted Sep 28, 4:59 PM ET
Guardian Pharmacy (GRDN) SVP Richard Eakins Converts 36,052 Shares
Accepted (ET)
4:59 PM
Sep 28, 2026
Filed
Sep 28, 2026
Documents
1
Size
7.1 KB
Summary
Guardian Pharmacy (GRDN) SVP Richard Eakins Converts 36,052 Shares
What Happened
Richard Eakins, Senior Vice President, Sales at Guardian Pharmacy Services (GRDN), reported a conversion/exercise-type transaction on September 27, 2026. The filing shows 36,052 shares were "acquired" and an equal 36,052 derivative shares were "disposed" (transaction code M). A footnote explains the Reporting Person's Class B common stock automatically converted one-for-one into Class A common stock under the company’s amended certificate of incorporation. No price or cash proceeds are reported.
Key Details
- Transaction date: 2026-09-27 (reported on Form 4 filed 2026-09-28) — filing appears timely.
- Transaction type/code: M = exercise/conversion of derivative (conversion of Class B into Class A).
- Shares involved: 36,052 converted (36,052 acquired as Class A; 36,052 derivative shares disposed).
- Price: N/A — no cash purchase or sale reported.
- Shares owned after transaction: not specified in the filing.
- Footnote: Automatic one-for-one conversion of Class B into Class A per the company’s Amended and Restated Certificate of Incorporation.
Context
This was a structural conversion of share class, not an open-market buy or sale — it does not indicate a market sale or new cash investment. For retail investors, conversions like this typically reflect capitalization/class changes rather than insider trading intent; they do not by themselves signal bullish or bearish insider sentiment.